Literature DB >> 2321657

Microcost analysis of inpatient dispensing and administration of oral solids.

H T Hatoum1.   

Abstract

The labor cost of dispensing, administering, and monitoring unit dose oral solid dosage forms (UDs) in a large teaching hospital was determined by microcost analysis. The costs associated with UDs dispensed by the midnight central pharmacy and by a satellite pharmacy were evaluated by use of both work-sampling and time-and-motion studies. Pharmacy personnel activities were classified as direct, auxiliary, or nonproductive. A nursing productivity index was used to determine the nursing time consumed in the administration and monitoring of UDs. The pharmacy labor cost was lowest ($0.14 each) for UDs dispensed from the central pharmacy in the 24-hour medication cart. For each UD that was not dispensed in the 24-hour cart, the labor cost was $0.25 for the central pharmacy and $1.37 for the satellite pharmacy. It took nurses 223.8 sec to administer and monitor a scheduled UD, for a cost of $0.82. The total nursing time spent per nonscheduled UD for administration and monitoring was 574.2 sec; the cost was $2.11. Microcost analysis can be used to isolate the costs of dispensing oral solids in an inpatient setting.

Entities:  

Mesh:

Year:  1990        PMID: 2321657

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  5 in total

Review 1.  Economic evaluation of pharmacy services--fact or fiction?

Authors:  B George; J Silcock
Journal:  Pharm World Sci       Date:  1999-08

2.  Economic evaluation of oral ofloxacin versus standard parenteral therapy in the treatment of pneumonia.

Authors:  J Menzin; D M Huse; R Richner; G Oster
Journal:  Pharmacoeconomics       Date:  1992-08       Impact factor: 4.981

3.  Cost-effectiveness of abbreviating the duration of intravenous antibacterial therapy with oral fluoroquinolones.

Authors:  K M Jensen; J A Paladino
Journal:  Pharmacoeconomics       Date:  1997-01       Impact factor: 4.981

4.  Cost effectiveness of ciprofloxacin plus metronidazole versus imipenem-cilastatin in the treatment of intra-abdominal infections.

Authors:  D J Walters; J S Solomkin; J A Paladino
Journal:  Pharmacoeconomics       Date:  1999-11       Impact factor: 4.981

5.  Direct costs in patients hospitalised with community-acquired pneumonia after non-response to outpatient treatment with macrolide antibacterials in the US.

Authors:  Joseph A Paladino; Martin H Adelman; Jerome J Schentag; Paul B Iannini
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.